By continuing to browse this site, you accept the use of cookies for the production of visit statistics. To find out more and configure cookies OK France Global Home | All CSL Behring sites | Contacts | Sitemap Research Include all CSL Behring country locations About CSL Behring Commitment to rare diseases Quality and safety Research and development Clinical studies Jobs and careers Transparency of links of interest Practitioners and students Professional associations 2012 Patient associations 2012 Other actors 2012 Scientific programs of events giving rise to a convention in 2012 Practitioners and students 2013 Professional associations 2013 Patient associations 2013 Other actors 2013 Scientific programs of events giving rise to a convention Public database Home > Transparency of links of interest Transparency of links of interest The 2011-2012 law of December 29, 2011 requires any company producing or marketing health products mentioned in article L. 5311-1 of the public health code to make public the agreements they enter into with health professionals. falling under the fourth part of the Public Health Code (CSP), students destined for these professions, as well as associations and groups representing them, associations of health professionals, associations of users of the health system, health establishments under Part Six of the CSP, foundations, learned societies and companies or consultancy bodies operating in the product sector, press publishing companies,publishers of radio or television services and publishers of online communication services to the public, publishers of software for prescribing and dispensing assistance and legal persons providing initial training for health professionals. CSL Behring, a subsidiary of CSL Limited is a biotechnology company specializing in the treatment of rare and serious diseases . A world leader in plasma collection and fractionation capacity , it produces and markets medicinal products derived from plasma in three therapeutic areas: coagulation, immunology and intensive care. CSL Behring invests in R&D and develops therapeutic proteins at the cutting edge of innovation to offer innovative treatments to patients, among others, suffering from deficiencies in the immune system or in coagulation factors . Consequently, the scientific collaboration between CSL Behring and Healthcare Professionals aims to: contribute to the continuing scientific training of doctors, pharmacists and hospital nurses, by financially supporting these actions, benefit from the advice and expertise of the most recognized practitioners in the context of medical research and expert groups, take on speakers or trainers to share their knowledge and skills with their peers, provide up-to-date, ethical and high added-value medical information to prescribers and nursing staff on our pharmaceutical specialties, collect and promote the information received in return from Healthcare Professionals during these meetings. In this context, CSL Behring's action can take the form of: a hospitality agreement which specifies the individual support provided to a Healthcare Professional through the payment of costs linked to their continuing education during a congress or a scientific meeting. The costs that can be covered are registration, transport, accommodation and catering costs. These agreements can be established with a Health Professional or with a student destined for these professions. a service agreement, implemented when a Healthcare Professional performs on behalf of CSL Behring a mission of expertise, clinical research investigator, trainer, scientific editor or speaker. This list is not exhaustive and any assignment entrusted to a Health Professional is subject to a written agreement (contract). These agreements can be established with a Health Professional, a student destined for these professions or an association of Health Professionals within the framework of a tripartite contract, impromptu hospitality: catering offered as part of normal working relations, for a modest amount and always within a professional framework. The impromptu and exceptional nature of these events does not require the prior establishment of a written agreement, a partnership or donation agreement to provide financial support to recognized associations of healthcare professionals in the implementation of their research and training actions. This aid supports the organization of congresses and other scientific events as well as the functioning of these associations. This financial support exclusively benefits all the members of the association and can in no way constitute an individual advantage for one of its members. Apart from Healthcare Professionals and their associations, CSL Behring also supports Patient associations, committed to supporting patients and taking charge of their pathology on a daily basis. Ces motivations encadrent et légitiment les aides accordées et les rémunérations versées en contrepartie de prestations réelles, et n’ont en aucune manière vocation à encourager la prescription de nos spécialités. Toutes les contributions versées font l’objet de la traçabilité et des déclarations requises par la réglementation. La publication ci-dessous concerne les conventions conclues et les avantages offerts aux Professionnels de Santé, aux étudiants se destinant à ces professions et aux associations de Professionnels de Santé, ainsi que les conventions conclues avec les organismes mentionnés à l’article L.1453-1 du Code de la Santé Publique. Conformément aux précisions apportées par le décret 2013-414 du 21 mai 2013 et de la circulaire n°DGS/PF2/2013/224 du 29 mai 2013, les publications seront effectuées pour CSL Behring SA sous la forme suivante : Professionnels de Santé et étudiants : Personnes Morales : Ces informations resteront accessibles sur ce site pendant une durée de cinq ans à compter de la date de leur publication. LOI INFORMATIQUE ET LIBERTE Les données personnelles visées dansl’article R1453-3 du Code de la santé publique sont publiées sur le site internet de CSL Behring pour répondre aux exigences légales relatives à la transparence des liens. Compte-tenu de l’organisation en place au sein du groupe CSL, les données collectées et traitées dans le cadre de la transparence des liens peuvent être transmises aux autres entités du groupe CSL Behring et aux prestataires agissant pour leur compte, dont certains sont situés en dehors de l’Union européenne (Suisse , Australie, Etats-Unis). CSL Behring SA s’assure d’un niveau de protection suffisant des données : la Suisse offre un niveau de protection adéquat des données à caractère personnel par décision de la Commission européenne du 26 juillet 2000, les destinataires situés aux Etats-Unis ont adhéré aux principes du Safe Harbor ou les transferts sont encadrés par la signature des clauses contractuelles types établies par la Commission européenne. Conformément à la loi « Informatiques et Libertés » du 6 janvier 1978 modifiée et au décret n°2005-1309 du 20 octobre 2005, les personnes mentionnées dans cette publication disposent d’un droit d’accès et de rectification aux informations qui les concernent en s’adressant au Référent CNIL de CSL Behring SA par email : infomedfrance@cslbehring.com ou par courrier :30 rue Cambronne, 75015 Paris. La transparence des liens relève d’une obligation légale de CSL Behring SA et les personnes concernées ne peuvent s’opposer au traitement de leurs données. Tableaux récapitulatifs Avantages et conventions établis 2012 Praticiens et étudiants Associations de professionnels Associations de patients Autres acteurs Programmes des manifestations 2012 Programmes scientifiques des événements ayant donné lieu à une convention Benefits and agreements established 2013 Practitioners and students Professional associations Patient associations Other actors 2013 events programs Scientific programs of events giving rise to a convention After 2013, you will be able to find all the information relating to the link of interest on the site set up by the government: Public database update: 06/30/2015 CSL Limited | CSL Behring Switzerland | CSL Plasma USA | Legal notices | Global Data Protection Policy | Cookies charter | FR / INS / 15-0007 / update: 02/18/2016 © 2016 CSL Behring